These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Immunopathology of cicatricial pemphigoid: studies of complement deposition. Rogers RS; Perry HO; Bean SF; Jordon RE J Invest Dermatol; 1977 Jan; 68(1):39-43. PubMed ID: 318674 [TBL] [Abstract][Full Text] [Related]
7. Pure ocular cicatricial pemphigoid. A distinct immunopathologic subset of cicatricial pemphigoid. Hoang-Xuan T; Robin H; Demers PE; Heller M; Toutblanc M; Dubertret L; Prost C Ophthalmology; 1999 Feb; 106(2):355-61. PubMed ID: 9951490 [TBL] [Abstract][Full Text] [Related]
8. Serum IgE levels in patients with bullous pemphigoid and its correlation to the activity of the disease and anti-basement membrane zone antibodies. Asbrink E; Hovmark A Acta Derm Venereol; 1984; 64(3):243-6. PubMed ID: 6204487 [TBL] [Abstract][Full Text] [Related]
9. Anti-basement membrane antibodies in sera from patients without bullous pemphigoid. Ullman S; Halberg P; Nielsen R Acta Derm Venereol; 1975; 55(4):305-8. PubMed ID: 52261 [TBL] [Abstract][Full Text] [Related]
10. Enigma of ocular cicatricial pemphigoid. A comparative study of clinical and immunological findings. Wright P Trans Ophthalmol Soc U K (1962); 1979 Apr; 99(1):141-5. PubMed ID: 398602 [TBL] [Abstract][Full Text] [Related]
11. Orf-induced immunobullous disease: A distinct autoimmune blistering disorder. White KP; Zedek DC; White WL; Simpson EL; Hester E; Morrison L; Lazarova Z; Liu D; Scagliarini A; Kurtz SE; White CR; Yancey KB; Blauvelt A J Am Acad Dermatol; 2008 Jan; 58(1):49-55. PubMed ID: 17919774 [TBL] [Abstract][Full Text] [Related]
12. Ocular cicatricial pemphigoid (immunologic studies). Bean SF; Furey N; West CE; Andrews T; Esterly NB Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol; 1976; 81(5):806-12. PubMed ID: 798368 [No Abstract] [Full Text] [Related]
13. Serum from normal elderly individuals contains anti-basement membrane zone antibodies. Hachisuka H; Kurose K; Karashima T; Mori O; Maeyama Y Arch Dermatol; 1996 Oct; 132(10):1201-5. PubMed ID: 8859031 [TBL] [Abstract][Full Text] [Related]
14. [Trials on bulla induction by antibodies from bullous pemphigoid patients in vivo and in vitro]. Lohrisch I; Noack H; Haustein UF; Sparmann G; Koch J Dermatol Monatsschr; 1985; 171(2):106-12. PubMed ID: 3884399 [No Abstract] [Full Text] [Related]
15. The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody. Jordon RE; Nordby JM; Milstein H J Lab Clin Med; 1975 Nov; 86(5):733-40. PubMed ID: 1102620 [TBL] [Abstract][Full Text] [Related]
16. Failure of specific human tissue substrates to increase the sensitivity of indirect immunofluorescence testing in cicatricial pemphigoid. Powell FC; Connolly SM; Rogers RS; Schroeter AL Acta Derm Venereol; 1984; 64(6):540-3. PubMed ID: 6084929 [TBL] [Abstract][Full Text] [Related]